Sphingomyelin d18:1/14:0 activates TLR4 in metaflammation
Eicke Latz(German Rheumatism Research Centre), Jan Van den Bossche(Amsterdam Neuroscience), Santu Singha(Massachusetts General Hospital), Eike Geißmar, Maximilian Rothe(Technical University of Munich), Mohamed Yaghmour, Jelena Zurkovic(University of Bonn), Mihai G. Netea(Radboud University Nijmegen), Michael G. FitzGerald(Broad Institute), Amin Polzin(Düsseldorf University Hospital), Friederike Gorki(Innate Pharma (France)), Arslan Hamid, Joost H.W. Rutten(Radboud University Nijmegen), Lenka Dohnalová(Goethe University Frankfurt), Niels P. Riksen(Radboud University Nijmegen), Kyra E. de Goede(Amsterdam University Medical Centers), Umeharu Ohto(The University of Tokyo), Jan K. Marzinek(Agency for Science, Technology and Research), Christoph A. Thaiss(Palo Alto Institute), Andreas Pfeiffer(Helmholtz Zentrum München), Anette Christ(Innate Pharma (France)), Katarzyna Placek(University of Bonn), Bodo Levkau(Düsseldorf University Hospital), Christoph Thiele(Life & Brain (Germany)), Peter J. Bond(Unilever (United Kingdom)), P Düwell(Innate Pharma (France)), Philipp Wollnitzke(Institute of Molecular Medicine)
Cited by 1
Related Papers
Defining trained immunity and its role in health and disease
|Nature reviews. Immunology|2020|2.5k
Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity
|Science|2016|2k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k